Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Gynecologic and Obstetric Investigation|December 18, 2004
Report of an early stopped randomized trial comparing cisplatin vs. cisplatin/ifosfamide/ 5-fluorouracil in recurrent cervical cancerIsabelle Cadron, Anders Jakobsen, Ignace VergoteCurrent Opinion in Obstetrics & Gynecology|January 15, 2011
The utility of proteomics in gynecologic cancersToon Van Gorp, Isabelle Cadron, Ignace VergoteMethods in Molecular Biology (Clifton, N.J.)|July 16, 2011
Proteomic analysis of laser microdissected ovarian cancer tissue with SELDI-TOF MSIsabelle Cadron, Toon Van Gorp, Philippe Moerman, et al.European Journal of Cancer (Oxford, England : 1990)|October 1, 2010
Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: an analysis of 163 patientsDimitris Tsolakidis, Frederic Amant, Karin Leunen, et al.Gynecologic Oncology|June 25, 2003
The diagnostic problem of endometrial stromal sarcoma: report on six casesFrédéric Amant, Philippe Moerman, Isabelle Cadron, et al.European Journal of Cancer (Oxford, England : 1990)|February 10, 2012
Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancerSofie Torfs, Isabelle Cadron, Frederic Amant, et al.Gynecologic Oncology|March 22, 2003
Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literatureFrédéric Amant, Philippe Moerman, Isabelle Cadron, et al.Gynecologic Oncology|September 7, 2007
Chemotherapy for recurrent cervical cancerIsabelle Cadron, Toon Van Gorp, Frederic Amant, et al.Gynecologic Oncology|May 15, 2007
The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancerIsabelle Cadron, Karin Leunen, Frédéric Amant, et al.Current Opinion in Oncology|August 9, 2006
The management of borderline tumours of the ovaryIsabelle Cadron, Frederic Amant, Toon Van Gorp, et al.Pageof 3